MAPT and Alzheimer disease: In conclusion, NLRP3 inflammasome activation may contribute to the progression of AD via production of pro-inflammatory cytokines such as IL-1β and reduction of Aβ and tau clearance, leading to increased deposition and formation of a self-perpetuating cycle [53].